Progenics Pharmaceuticals Shares Up 19.4% Since SmarTrend's Buy Recommendation (PGNX)
August 25, 2016 at 02:19 AM EDT
SmarTrend identified an Uptrend for Progenics Pharmaceuticals (NASDAQ:PGNX) on July 8th, 2016 at $5.49. In approximately 2 months, Progenics Pharmaceuticals has returned 19.42% as of today's recent price of...